The value of immunoglobulin g avidity test for the serological diagnosis of brucellosis;Brusellozi̇si̇n seroloji̇k tanisinda i̇mmü noglobuli̇n g avi̇di̇te testi̇ni̇n deǧeri̇

Mikrobiyoloji Bulteni

Volumn 37, Issue 4, 2003, Pages 261-267

  Sayin Kutlu, Selda ^a   Çelikbaş, Aysel ^a   Ergönül, Önder ^a   Kutlu, Murat ^a   Aksaray, Sebahat ^a   Güvener, Engin ^a   Dokuzoǧuz, Başak ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Brucellosis; IgG avidity test; Serologic diagnosis

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; UREA; BACTERIUM ANTIBODY;

ADULT; AGGLUTINATION TEST; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; BLOOD CULTURE; BRUCELLA; BRUCELLOSIS; CLINICAL FEATURE; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN G AVIDITY TEST; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; REFERENCE VALUE; SERODIAGNOSIS; ADOLESCENT; AGED; ANTIBODY AFFINITY; BACTEREMIA; BLOOD; EVALUATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGGLUTINATION TESTS; ANTIBODIES, BACTERIAL; ANTIBODY AFFINITY; BACTEREMIA; BRUCELLA; BRUCELLOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; TIME FACTORS;

EID: 3042818607     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Young EJ: Serologic diagnosis of human brucellosis: Analysis of 214 cases by agglutination tests and review of the literature. Rev Infect Dis 1991, 13: 359-372.
2. Casanas MC, Queipo-Ortuno MI, Rodriguez-Torres A, Orduna A, Colmenero JD, Morata P: Specificity of a PCR assay of a target sequence on the 31-kilodalton Brucella antigen DNA used to diagnose human brucellosis. Eur J Clin Microbiol Infect Dis 2001, 20: 127-131.
3. Matar GM, Khneisser IA, Abdelnoor AM: Rapid laboratory confirmation of human brucellosis by PCR analysis of target sequence on the 31-kilodalton Brucella antigen. J Clin Microbiol 1996, 34: 477-478.
4. Goldbaum FA, Rubbi CP, Wallach JC, et al: Differentiation between active and inactive human brucellosis by measuring antiprotein humoral immune responses. J Clin Microbiol 1992, 30: 604-607.
5. Strasek K, Marin J: Epstein-Barr virus infections: Avidity test for IgG antibodies. Zdrav Vestn 2001, 70: 321-323.
6. Liesenfeld O, Montoya JG, Kinney S, Press C, Remington JS: Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: Experience in a US reference laboratory. J Infect Dis 2001, 183: 1248-1253.
7. Mechain B, Garin YJF, Robert-Gangneux F, Dupouy-Camet J, Derouin F: Lack of utility of specific immunoglobulin G antibody avidity for serodiagnosis of reactivated toxoplasmosis in immunocompromised patients. Clin Diag Lab Immunol 2000, 7: 703-705.
8. Logar J, Novak-Antolic Z, Zore A: Specific IgG avidity: A supplementary assay in serolojical screening for toxoplasmosis in pregnancy. J Infect 1999, 38: 61-63.
9. Bodeus M, Beulne D, Goubau P: Ability of three IgG-avidity assays to exclude recent cytomegalovirus infection. Eur J Clin Microbiol Infect Dis 2001, 20: 248-252.
10. Gutierrez J, Rodriguez MJ, De Ory F, Piedrola G, Maroto MC: Reliability of low-avidity IgG and of IgA in the diagnosis of primary infection by Rubella virus with adaptation of a commercial test. J Clin Lab Anal 1999, 13: 1-4.
11. Çolak D: infeksiyon hastaliklarinin tanisinda immünglobulin G avidite testleri. Ankem Derg 2001, 15: 621-624.
12. Gutierrez J, Maroto C: Are IgG antibody avidity assays useful in the diagnosis of infectious diseases? A review. Microbios 1996, 87: 113-121.
13. Prince H, Wilson M: Simplified assays for measuring Toxoplasma gondii IgG avidity. Clin Diag Lab Immunol 2001, 8: 904-908.
14. Schubert J, Zens W, Weissbrich B: Comparative evaluation of the use of immunoblots and of IgG avidity assays as confirmatory tests for the diagnosis of the acute EBV infections. J Clin Virol 1998, 11: 161-172.
15. Gutierrez JF, Rodriguez M, Maroto MC: Relationship between evaluation time of human brucellosis and the avidity of specific IgG antibodies. Rev Med Chile 1995, 123: 819-822.
16. th ed. Mosby-Year Book, London.
17. th ed. Mosby-Year Book, St. Louis.
18. Ward KN, Turner DJ, Prada XC, Thiruchelvam AD: Use of IgG antibody avidity for differentiation of primary human herpesvirus 6 and 7 infections. J Clin Microbiol 2001, 39: 959-963.
19. Rauer S, Beitlich P, Neubert U, Rasiah C, Kaiser R: Avidity determination of Borrellia burgdorferi-specific IgG antibodies in Lyme disease. Scand J Infect Dis 2001, 33: 809-811.
20. Korhonen MH, Brunstein J, Haario H, Katnikov A, Rescaldani R, Hedman K: A new method with general diagnostic utility for the calculation of immunoglobulin G avidity. Clin Diag Lab Immunol 1999, 6: 725-728.
21. th ed. Churchill Livingstone, New York.
22. Wuorimaa T, Dagan R, Vakevainen M, et al: Avidity and subclasses of IgG after immunization of infants with an 11- valent pneumococcal conjugate vaccine with or without aluminium adjuvant. J Infect Dis 2001, 184: 1211-1215.
23. Pelloux H, Brun E, Vernet G, et al: Determination of anti-Toxoplasma gondii IgG avidity: Adaptation to the Vidas system (BioMerieux). Diagn Microbiol Infect Dis 1998, 32: 69-73.
24. Cozon GJN, Ferrandiz J, Nebhi H, Wallon M, Peyron F: Estimation of the avidity of IgG for routine diagnosis of chronic Toxoplasma gondii infection in pregnant women. Eur J Clin Microbiol Infect Dis 1998, 17: 32-36.